KAPA
Kairos Pharma·AMEX
--
--(--)
--
--(--)
8.69 / 10
Outperform
Analyst consensus is overwhelmingly bullish: two Strong Buy calls (100%) from D. Boral Capital, with a weighted rating of 10.23. Fund‑flow score is 7.14 (good), showing modest overall inflows but negative trends in larger blocks. Sentiment remains positive.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-19
InstitutionD. Boral Capital
Times predicted9
Historical Win Rate44.4%
What is the market sentiment for KAPA?
- KAPA holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 8.69/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
